Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Innospec (IOSP) Operating Expenses (2016 - 2025)

Innospec (IOSP) has disclosed Operating Expenses for 16 consecutive years, with $80.6 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 15.25% to $80.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $362.9 million through Dec 2025, down 0.58% year-over-year, with the annual reading at $362.9 million for FY2025, 0.58% down from the prior year.
  • Operating Expenses hit $80.6 million in Q4 2025 for Innospec, down from $110.8 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $116.2 million in Q2 2023 to a low of $71.3 million in Q2 2021.
  • Historically, Operating Expenses has averaged $93.0 million across 5 years, with a median of $94.2 million in 2022.
  • Biggest five-year swings in Operating Expenses: tumbled 36.62% in 2021 and later soared 41.15% in 2025.
  • Year by year, Operating Expenses stood at $77.4 million in 2021, then skyrocketed by 35.66% to $105.0 million in 2022, then increased by 5.9% to $111.2 million in 2023, then decreased by 14.48% to $95.1 million in 2024, then fell by 15.25% to $80.6 million in 2025.
  • Business Quant data shows Operating Expenses for IOSP at $80.6 million in Q4 2025, $110.8 million in Q3 2025, and $88.9 million in Q2 2025.